American Vanguard faces a challenging outlook characterized by inconsistent revenue growth and significant exposure to regulatory risks regarding its core organophosphate portfolio. While the company maintains a low capital intensity with CapEx/Revenue ratios ...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 10, 2026 | -$0.34-477.8% vs $0.09 | $117M-13.5% vs $135M |
Q2 2026 May 6, 2026 | -$0.14-133.3% vs -$0.06 | $124M+3.0% vs $120M |
Q2 2026 Mar 16, 2026 | $0.06-78.6% vs $0.28 | $151M-7.6% vs $163M |
Q4 2025 Nov 10, 2025 | -$0.18-125.0% vs -$0.08 | $119M-6.8% vs $128M |
IRVINE, CA / ACCESS Newswire / August 11, 2026 / American Vanguard Corporation (NYSE:AVD) today announced Mark Helt joined the company as U.S. Crop President. Mark brings more than 25 years of commercial leadership experience across the North American crop protection, seed, and specialty markets.
American Vanguard NYSE: AVD reported lower second-quarter sales amid challenging agricultural market conditions, while management said U.S. specialty growth, cost actions and product-development investments supported its full-year outlook.
American Vanguard Corporation (AVD) Q2 2026 Earnings Call Transcript
IRVINE, CA / ACCESS Newswire / August 10, 2026 / American Vanguard Corporation, a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and nutrition, turf and ornamental management and commercial pest control, today reported financial results for the second quarter and six-months ended June 30, 2026.
Benchmark AVD against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for American Vanguard Corporation (AVD)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $2.03 | $58.07M | -1.16 | -5.88% | -9.68% | -23.45% | — | |
| $11.54 | $266.72M | 6.48 | 25.18% | 10.38% | 7.11% | — | |
| $1.33 | $46.21M | 13.30 | 12.61% | -29.63% | -22.57% | — | |
| $33.62 | $936.63M | -76.41 | 2.49% | -9.48% | -3.42% | — | |
| $18.68 | $4.06B | -4.95 | 10.52% | 5.58% | 14.7% | — | |
| $96.60 | $2.38B | 20.69 | -3.65% | 6.6% | 9.1% | — |
American Vanguard Corporation (AVD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
American Vanguard Corporation (AVD) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 11, 2026·SEC
Jun 8, 2026·SEC
Apr 15, 2026·SEC
Get notified when AVD posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
American Vanguard Corporation (AVD) stock FAQ — growth, dividends, profitability & financials explained
American Vanguard Corporation (AVD) reported $510.3M in revenue for fiscal year 2025. This represents a 950% increase from $48.6M in 1996.
American Vanguard Corporation (AVD) saw revenue decline by 5.9% over the past year.
American Vanguard Corporation (AVD) reported a net loss of $54.6M for fiscal year 2025.
American Vanguard Corporation (AVD) has a return on equity (ROE) of -23.4%. Negative ROE indicates the company is unprofitable.
American Vanguard Corporation (AVD) had negative free cash flow of $47.1M in fiscal year 2025, likely due to heavy capital investments.
